Preexisting Autoimmune Disease Increases Incidence of irAEs With PD-1 Immunotherapy for Advanced Cancer
Study findings demonstrate the rates of immune-related adverse events and flares of the underlying disorders in this patient population.
All articles by Katie Kosko
New Guidelines Help Decision Making for the Prevention, Management of Venous Thromboembolism
The American Society of Hematology released guidelines for preventing and managing venous thromboembolism in patients with cancer.
Risk Factors Associated With Chemotherapy-Induced Peripheral Neuropathy
Researchers identified the risk factors for chemotherapy-induced peripheral neuropathy in cancer patients treated with paclitaxel or oxaliplatin.
Hypertension, Older Age Are Significant Risk Factors for Bleomycin-Induced Lung Injury
Investigators sought to determine the incidence of BLI on patients with cancer receiving bleomycin-containing regimens.
Azacitidine Plus Venetoclax Is Not Cost-Effective for Some Patients With AML
Cost-effectiveness model was developed to compare costs and other factors of azacitidine/venetoclax combination with azacitidine alone in patients with AML.
- Loading...
Loading...
Loading... 
Loading...